C21 · Pharmaceuticals · China
Share of high-value-added products in pharmaceutical exports (half year)
China: 20% in January–June 2026.
- 20% Latest · China · January–June 2026
- Irregular Release cadence
- 1 Record · 1 region · 2026
Verified 17 Sep 2026 · 1 publisher · Next period July–December 2026
The figure
One published observation so far. A chart follows as soon as a second period is published.
Every record
1 record · 1 region · 2026. Each period links to its record: the value, its source evidence and original document.
| Period | Value | Source | Type |
|---|---|---|---|
| China 1 record | |||
| January–June 2026 | 20% | MOFCOM · 30 Jun 2026 | |
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: MOFCOM. Licence: CC BY 4.0.
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (MOFCOM); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Proportion of high-value-added products such as chemical preparations and biological products in total pharmaceutical exports.
- Measure
- One slice of Sales ( form: share, origin: exported, segment: high value added ) . Total monetary amount of sales revenue generated. Region and period are columns on every record, not slices.
- Limitations
- Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 1 document
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 上半年我国创新药对外技术授权交易额创新高 | MOFCOM | — | 1 |
Other slices of sales
- Electric cars as a share of new car sales 15 electric car
- Electric car sales 13 electric car
- Battery-electric cars as a share of new car registrations 7 registration · bev
- New passenger car registrations 3 registration · passenger car
- Battery-electric car registrations 2 registration · bev
- Commercial electricity sales growth 2 commercial electricity
- Cumulative plug-in electric vehicle sales 2 cumulative · plug in electric
- E-commerce sales 2 e commerce
- Electric car exports 2 exported · electric car
- Electric car sales growth rate 2 electric car
- Electric trucks as a share of truck sales 2 electric truck
- Electricity sales growth 2 electricity
Frequently asked questions
What is the latest share of high-value-added products in pharmaceutical exports (half year)?
China: 20% in January–June 2026.
Where does this data come from?
From 1 document published by MOFCOM. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Irregularly: the publishers behind this measure do not release it on a fixed schedule. A new figure appears here once it is published and verified.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Share of high-value-added products in pharmaceutical exports (half year) [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/share-of-high-value-added-products-in-pharmaceutical-exports-half-year
"Share of high-value-added products in pharmaceutical exports (half year)." StatOrigin, 2026, https://statorigin.org/indicators/share-of-high-value-added-products-in-pharmaceutical-exports-half-year. Accessed 28 Oct. 2026.
StatOrigin. "Share of high-value-added products in pharmaceutical exports (half year)." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/share-of-high-value-added-products-in-pharmaceutical-exports-half-year.
@misc{statorigin_share_of_high_value_added_products_in_pharmaceutical_exports_half_year_2026, title = {Share of high-value-added products in pharmaceutical exports (half year)}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/share-of-high-value-added-products-in-pharmaceutical-exports-half-year}, note = {Data set. Accessed 2026-10-28} }